Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC)

ABSTRACT: A phase II trial was launched to evaluate if neoadjuvant stereotactic ablative radiotherapy (SABR) before surgery improves oncologic outcomes in patients with stage I non-small cell lung cancer (NSCLC). We report a mandated interim safety analysis for the first 10 patients who completed pr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Radiat Oncol
Autori principali: Palma, David A., Nguyen, Timothy K., Kwan, Keith, Gaede, Stewart, Landis, Mark, Malthaner, Richard, Fortin, Dalilah, Louie, Alexander V., Frechette, Eric, Rodrigues, George B., Yaremko, Brian, Yu, Edward, Dar, A. Rashid, Lee, Ting-Yim, Gratton, Al, Warner, Andrew, Ward, Aaron, Inculet, Richard
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2017
Soggetti:
Short Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5270342/
https://ncbi.nlm.nih.gov/pubmed/28129789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-017-0770-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi